Matches in Wikidata for { <http://www.wikidata.org/entity/Q82892839> ?p ?o ?g. }
- Q82892839 description "2006 nî lūn-bûn" @default.
- Q82892839 description "2006年の論文" @default.
- Q82892839 description "2006年学术文章" @default.
- Q82892839 description "2006年学术文章" @default.
- Q82892839 description "2006年学术文章" @default.
- Q82892839 description "2006年学术文章" @default.
- Q82892839 description "2006年学术文章" @default.
- Q82892839 description "2006年学术文章" @default.
- Q82892839 description "2006年學術文章" @default.
- Q82892839 description "2006年學術文章" @default.
- Q82892839 description "2006年學術文章" @default.
- Q82892839 description "2006年學術文章" @default.
- Q82892839 description "2006年學術文章" @default.
- Q82892839 description "2006년 논문" @default.
- Q82892839 description "article científic" @default.
- Q82892839 description "article scientific" @default.
- Q82892839 description "article scientifique" @default.
- Q82892839 description "articol științific" @default.
- Q82892839 description "articolo scientifico" @default.
- Q82892839 description "artigo científico" @default.
- Q82892839 description "artigo científico" @default.
- Q82892839 description "artigo científico" @default.
- Q82892839 description "artikel ilmiah" @default.
- Q82892839 description "artikull shkencor" @default.
- Q82892839 description "artikulong pang-agham" @default.
- Q82892839 description "artykuł naukowy" @default.
- Q82892839 description "artículo científico publicado en 2006" @default.
- Q82892839 description "artículu científicu" @default.
- Q82892839 description "bilimsel makale" @default.
- Q82892839 description "bài báo khoa học" @default.
- Q82892839 description "naučni članak" @default.
- Q82892839 description "scienca artikolo" @default.
- Q82892839 description "scientific article published in April 2006" @default.
- Q82892839 description "scientific article published in April 2006" @default.
- Q82892839 description "scientific article published on 01 April 2006" @default.
- Q82892839 description "teaduslik artikkel" @default.
- Q82892839 description "tieteellinen artikkeli" @default.
- Q82892839 description "tudományos cikk" @default.
- Q82892839 description "vedecký článok" @default.
- Q82892839 description "vetenskaplig artikel" @default.
- Q82892839 description "videnskabelig artikel udgivet april 2006" @default.
- Q82892839 description "vitenskapelig artikkel" @default.
- Q82892839 description "vitskapeleg artikkel" @default.
- Q82892839 description "vědecký článek" @default.
- Q82892839 description "wetenschappelijk artikel" @default.
- Q82892839 description "wissenschaftlicher Artikel" @default.
- Q82892839 description "επιστημονικό άρθρο" @default.
- Q82892839 description "мақолаи илмӣ" @default.
- Q82892839 description "наукова стаття, опублікована у квітні 2006" @default.
- Q82892839 description "научна статия" @default.
- Q82892839 description "научная статья" @default.
- Q82892839 description "научни чланак" @default.
- Q82892839 description "научни чланак" @default.
- Q82892839 description "מאמר מדעי" @default.
- Q82892839 description "مقالة علمية نشرت في أبريل 2006" @default.
- Q82892839 description "এপ্রিল ২০০৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q82892839 description "บทความทางวิทยาศาสตร์" @default.
- Q82892839 description "სამეცნიერო სტატია" @default.
- Q82892839 name "Phase II, open-label, randomized study (SIGN) of single-agent gefitinib (IRESSA) or docetaxel as second-line therapy in patients with advanced (stage IIIb or IV) non-small-cell lung cancer" @default.
- Q82892839 name "Phase II, open-label, randomized study (SIGN) of single-agent gefitinib (IRESSA) or docetaxel as second-line therapy in patients with advanced (stage IIIb or IV) non-small-cell lung cancer" @default.
- Q82892839 type Item @default.
- Q82892839 label "Phase II, open-label, randomized study (SIGN) of single-agent gefitinib (IRESSA) or docetaxel as second-line therapy in patients with advanced (stage IIIb or IV) non-small-cell lung cancer" @default.
- Q82892839 label "Phase II, open-label, randomized study (SIGN) of single-agent gefitinib (IRESSA) or docetaxel as second-line therapy in patients with advanced (stage IIIb or IV) non-small-cell lung cancer" @default.
- Q82892839 prefLabel "Phase II, open-label, randomized study (SIGN) of single-agent gefitinib (IRESSA) or docetaxel as second-line therapy in patients with advanced (stage IIIb or IV) non-small-cell lung cancer" @default.
- Q82892839 prefLabel "Phase II, open-label, randomized study (SIGN) of single-agent gefitinib (IRESSA) or docetaxel as second-line therapy in patients with advanced (stage IIIb or IV) non-small-cell lung cancer" @default.
- Q82892839 P1433 Q82892839-D64CE8D3-E2ED-4478-AC80-CA0D4055CDD7 @default.
- Q82892839 P1476 Q82892839-25CB877A-6EB0-4B3E-AF78-264D5FB80300 @default.
- Q82892839 P2093 Q82892839-10221607-C0BB-48A2-A7EB-0CCE80AA07FC @default.
- Q82892839 P2093 Q82892839-85CB87F9-18EA-4B40-9DA8-AFBA056D1AA9 @default.
- Q82892839 P2093 Q82892839-9C38B6CE-5E66-4E59-A245-EBE70C66EA13 @default.
- Q82892839 P2093 Q82892839-A1595261-9DCD-443C-A58D-C9445B79CB32 @default.
- Q82892839 P2093 Q82892839-B1581F06-1FE8-4FB4-B610-43FC810FC068 @default.
- Q82892839 P2093 Q82892839-FB63E65D-219F-4611-AF8D-AC3E7C2B7F50 @default.
- Q82892839 P304 Q82892839-0845488E-9D91-4BE5-8B18-5BC720672F25 @default.
- Q82892839 P31 Q82892839-DF47F7CD-732D-40CB-A01D-53BA794196F4 @default.
- Q82892839 P356 Q82892839-1237B5D2-18B5-40C0-9F71-3F4F4B8E55F7 @default.
- Q82892839 P433 Q82892839-BBAB1751-669D-49FF-B679-52C83B2663B2 @default.
- Q82892839 P478 Q82892839-F048207D-C353-42B7-8678-7CB554E79E96 @default.
- Q82892839 P577 Q82892839-24F972F3-5DC3-4BFA-B674-93A64F7C40CF @default.
- Q82892839 P698 Q82892839-8CD8E5CA-40C3-4AE6-82FE-7D0A9A26EA2F @default.
- Q82892839 P921 Q82892839-6195C6CE-0A6B-411D-900B-38CD726DED9E @default.
- Q82892839 P921 Q82892839-8E049AD9-CAA5-4434-A646-D7088FD9C696 @default.
- Q82892839 P356 01.CAD.0000203381.99490.AB @default.
- Q82892839 P698 16549997 @default.
- Q82892839 P1433 Q4774128 @default.
- Q82892839 P1476 "Phase II, open-label, randomized study (SIGN) of single-agent gefitinib (IRESSA) or docetaxel as second-line therapy in patients with advanced (stage IIIb or IV) non-small-cell lung cancer" @default.
- Q82892839 P2093 "Eduard Vrdoljak" @default.
- Q82892839 P2093 "Inci Erensoy" @default.
- Q82892839 P2093 "Kristine Pemberton" @default.
- Q82892839 P2093 "Rabab Gaafar" @default.
- Q82892839 P2093 "SIGN Study Group" @default.
- Q82892839 P2093 "Tanja Cufer" @default.
- Q82892839 P304 "401-409" @default.
- Q82892839 P31 Q13442814 @default.
- Q82892839 P356 "10.1097/01.CAD.0000203381.99490.AB" @default.
- Q82892839 P433 "4" @default.
- Q82892839 P478 "17" @default.
- Q82892839 P577 "2006-04-01T00:00:00Z" @default.
- Q82892839 P698 "16549997" @default.
- Q82892839 P921 Q420436 @default.